"Immunity, Innate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The capacity of a normal organism to remain unaffected by microorganisms and their toxins. It results from the presence of naturally occurring ANTI-INFECTIVE AGENTS, constitutional factors such as BODY TEMPERATURE and immediate acting immune cells such as NATURAL KILLER CELLS.
| Descriptor ID |
D007113
|
| MeSH Number(s) |
G12.450.564
|
| Concept/Terms |
Immunity, Innate- Immunity, Innate
- Immunity, Non-Specific
- Immunity, Non Specific
- Non-Specific Immunity
- Innate Immune Response
- Immune Response, Innate
- Immune Responses, Innate
- Innate Immune Responses
- Immunity, Native
- Native Immunity
- Innate Immunity
- Immunity, Natural
- Natural Immunity
|
Below are MeSH descriptors whose meaning is more general than "Immunity, Innate".
Below are MeSH descriptors whose meaning is more specific than "Immunity, Innate".
This graph shows the total number of publications written about "Immunity, Innate" by people in this website by year, and whether "Immunity, Innate" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 2 | 3 |
| 1997 | 0 | 1 | 1 |
| 1998 | 0 | 2 | 2 |
| 1999 | 1 | 3 | 4 |
| 2000 | 0 | 5 | 5 |
| 2001 | 0 | 10 | 10 |
| 2002 | 0 | 4 | 4 |
| 2003 | 2 | 8 | 10 |
| 2004 | 6 | 10 | 16 |
| 2005 | 5 | 13 | 18 |
| 2006 | 6 | 12 | 18 |
| 2007 | 14 | 6 | 20 |
| 2008 | 16 | 11 | 27 |
| 2009 | 13 | 13 | 26 |
| 2010 | 9 | 22 | 31 |
| 2011 | 21 | 13 | 34 |
| 2012 | 21 | 21 | 42 |
| 2013 | 19 | 15 | 34 |
| 2014 | 22 | 13 | 35 |
| 2015 | 17 | 9 | 26 |
| 2016 | 14 | 22 | 36 |
| 2017 | 12 | 15 | 27 |
| 2018 | 13 | 12 | 25 |
| 2019 | 12 | 21 | 33 |
| 2020 | 15 | 11 | 26 |
| 2021 | 13 | 7 | 20 |
| 2022 | 6 | 9 | 15 |
| 2023 | 1 | 18 | 19 |
| 2024 | 14 | 7 | 21 |
| 2025 | 6 | 4 | 10 |
| 2026 | 6 | 9 | 15 |
To return to the timeline,
click here.
Below are the most recent publications written about "Immunity, Innate" by people in Profiles.
-
Krönke G, Schett G, Latz E. Molecular underpinnings of rheumatic diseases and emerging therapeutic concepts. Nature. 2026 Oct; 658(8138):1141-1152.
-
Simwela NV, Johnston L, Sassetti CM, Russell DG. Ubiquitylation by the GID/CTLH complex regulates the metabolic and innate immune response of macrophages to infection by Mycobacterium tuberculosis. PLoS Pathog. 2026 Sep; 22(9):e1014196.
-
Ogunsola AF, Lai R, Cavallo K, Tran AV, Beamer GL, Behar SM. BCG vaccination elicits protection against M. tuberculosis infection mediated by two phases of T cell immunity. JCI Insight. 2026 08 24; 11(16).
-
Suzuki M, Hasegawa Y, Zhang H, Liang Z, Tie G, Shivdasani RA, Waldor MK. IL-22 promotes genesis of small intestinal secretory cells that protect against cholera in mice. Nat Microbiol. 2026 Jul; 11(7):1949-1966.
-
Pham LK, Cervantes MM, Lim PN, Dubey D, Tufts A, Mitchell MC, Shinkawa T, Behar SM, Rothchild AC. NRF2-mediated inhibition of alveolar macrophage MHC II expression during Mycobacterium tuberculosis infection. Cell Rep. 2026 Jun 23; 45(6):117397.
-
Steinbuck MP, Seenappa LM, Zhan W, Palmer E, Jung MM, Jakubowski A, Cabana-Puig X, McNeil LK, Haqq CM, Fitzgerald KA, DeMuth PC. Lymph node-targeted DNA engages TBK1/IFN-I-driven innate immunity to induce potent T cell responses and durable memory in mice and NHPs. Sci Adv. 2026 May 29; 12(22):eaec1416.
-
Lee D, Lu MP, Rajamanimuthu P, Das M, Ferraj E, Fisher C, Matatia P, Chen CW, Geha RS, Sokol CL, Gowthaman U. Interleukin-4-producing type 2 innate lymphoid cells in the lymph node promote proallergic Tfh13 cell differentiation. Immunity. 2026 Jul 14; 59(7):1860-1875.e7.
-
Ortega-Ribera M, Brenig R, Bernsmeier C, Szabo G. Uncovering immune dysfunction in ACLF: Cellular mechanisms, molecular pathways, and therapeutic frontiers. J Hepatol. 2026 Sep; 85(3):612-629.
-
Parajuli S, Gallagher T, Flotte TR. Immune Toxicities in AAV Gene Therapy: Overview for Clinicians. Int J Mol Sci. 2026 Mar 31; 27(7).
-
Winther KG, Schneider J, Haas G, Christensen AH, Goyal S, Luo W, Wei Z, Liu J, Kjøge K, Enghild JJ, Meignin C, Silverman N, Cai H, Imler JL, Hartmann R. FADD is recruited to activated STING oligomers to initiate caspase-mediated NF-?B activation in Drosophila melanogaster. EMBO J. 2026 May; 45(9):2965-2990.